Literature DB >> 31863828

Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): More than a mere co-morbidity.

Katja Rietdorf1, Emily E Coode2, Angela Schulz3, Eva Wibbeler3, Martin D Bootman2, John R Ostergaard4.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are mostly seen as diseases affecting the central nervous system, but there is accumulating evidence that they have co-morbidities outside the brain. One of these co-morbidities is a decline in cardiac function. This is becoming increasingly recognised in teenagers and adolescents with juvenile CLN3, but it may also occur in individuals with other NCLs. The purpose of this review is to summarise the current knowledge of the structural and functional changes found in the hearts of animal models and people diagnosed with NCL. In addition, we present evidence of structural changes that were observed in a systematic comparison of the cardiomyocytes from CLN3Δex7/8 mice.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Batten disease; Cardiac pathology; Cardiomyocyte structure; ECG; Echocardiogram; Juvenile CLN3

Year:  2019        PMID: 31863828     DOI: 10.1016/j.bbadis.2019.165643

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  9 in total

1.  Batten disease: an expert update on agents in preclinical and clinical trials.

Authors:  Margaux C Masten; Jonathan W Mink; Erika F Augustine
Journal:  Expert Opin Investig Drugs       Date:  2020-11-01       Impact factor: 6.206

Review 2.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

Review 4.  Mitochondria and Calcium Homeostasis: Cisd2 as a Big Player in Cardiac Ageing.

Authors:  Chi-Hsiao Yeh; Yi-Ju Chou; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

5.  Pacemaker Implantation in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)-A Long-Term Follow-Up Study.

Authors:  Mette Møller Handrup; Henning Mølgaard; Brian N Andersen; John R Ostergaard
Journal:  Front Neurol       Date:  2022-03-10       Impact factor: 4.003

6.  Cardiac magnetic resonance findings in neuronal ceroid lipofuscinosis: A case report.

Authors:  Giancarlo Todiere; Stefania Della Vecchia; Maria Aurora Morales; Andrea Barison; Ivana Ricca; Alessandra Tessa; Elisa Colombi; Filippo Maria Santorelli
Journal:  Front Neurol       Date:  2022-08-22       Impact factor: 4.086

7.  Tripeptidyl Peptidase 1 (TPP1) Deficiency in a 36-Year-Old Patient with Cerebellar-Extrapyramidal Syndrome and Dilated Cardiomyopathy.

Authors:  Agnieszka Ługowska; Joanna K Purzycka-Olewiecka; Rafał Płoski; Grażyna Truszkowska; Maciej Pronicki; Paulina Felczak; Mateusz Śpiewak; Aleksandra Podlecka-Piętowska; Martyna Sitek; Zofia T Bilińska; Przemysław Leszek; Małgorzata Bednarska-Makaruk
Journal:  Life (Basel)       Date:  2021-12-21

Review 8.  Altered protein secretion in Batten disease.

Authors:  Robert J Huber
Journal:  Dis Model Mech       Date:  2021-12-06       Impact factor: 5.758

9.  CLN3, at the crossroads of endocytic trafficking.

Authors:  Susan L Cotman; Stéphane Lefrancois
Journal:  Neurosci Lett       Date:  2021-07-16       Impact factor: 3.197

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.